Properties
Description
GSK163090 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT1A receptor, 5-HT1B receptor, 5-HT1D receptor, 5-HT2A receptor, 5-HT2B receptor, 5-HT2C receptor, D2 receptor, D3 receptor, human 5-HT6 receptor, and human 5-HT7 receptor.
Molecular Formula
C25H29N5O
Targets
5-HT1A receptor: 9.4 (pKi); 5-HT1B receptor: 8.5 (pKi); 5-HT1D receptor: 9.7 (pKi); 5-HT2A receptor: 6 (pKi); 5-HT2B receptor: 6.3 (pKi); 5-HT2C receptor: 5.8 (pKi); D2 receptor: 6.3 (pKi); D3 receptor: 6.7 (pKi); Human 5-HT6 receptor: <5.3 (pKi); Human 5-HT7 receptor: 6.8 (pKi)
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
GSK163090 can be used for its effects on neurological function and its potential role in modulating neurotransmitter systems within the brain.
Storage
Store at -20°C, and keep desiccated.